A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
Clinical trial NCT06044337 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06044337
- Sponsor
- Biogen
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-03
- Primary completion
- 2029-06-26
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.